Vx-770


Indications and Reactions:

Role Indications Reactions
Primary
Cystic Fibrosis 76.5%
Cystic Fibrosis Lung 6.1%
Pancreatic Insufficiency 2.2%
Cough 1.3%
Medical Diet 1.3%
Nutritional Supplementation 1.3%
Asthma 0.9%
Constipation 0.9%
Dyspnoea 0.9%
Gastrooesophageal Reflux Disease 0.9%
General Anaesthesia 0.9%
Hypovitaminosis 0.9%
Nasal Polyps 0.9%
Upper Respiratory Tract Infection 0.9%
Chronic Sinusitis 0.7%
Hyponatraemia 0.7%
Productive Cough 0.7%
Prophylaxis 0.7%
Rhinitis Allergic 0.7%
Vitamin Supplementation 0.7%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 16.9%
Weight Increased 11.6%
Nasopharyngitis 11.0%
Sinusitis 5.8%
Pulmonary Function Test Decreased 5.2%
Treatment Noncompliance 5.2%
Cough 4.1%
Headache 4.1%
Constipation 3.5%
Drug Ineffective 3.5%
Migraine 3.5%
Pneumonia 3.5%
Pseudomonas Infection 3.5%
Vomiting 3.5%
Antibiotic Prophylaxis 2.9%
Rash 2.9%
Diarrhoea 2.3%
Hospitalisation 2.3%
Influenza 2.3%
Pyrexia 2.3%
Secondary
Cystic Fibrosis 47.8%
Cystic Fibrosis Lung 8.9%
Pancreatic Insufficiency 7.8%
Asthma 6.7%
Medical Diet 4.4%
Nutritional Supplementation 3.3%
Rhinitis Allergic 3.3%
Gastrooesophageal Reflux Disease 2.2%
Hyponatraemia 2.2%
Staphylococcal Infection 2.2%
Antibiotic Prophylaxis 1.1%
Blood Sodium Decreased 1.1%
Hypertension 1.1%
Hypovitaminosis 1.1%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 1.1%
Nasal Polyps 1.1%
Nutritional Support 1.1%
Pain 1.1%
Productive Cough 1.1%
Prophylaxis 1.1%
Infective Pulmonary Exacerbation Of Cystic Fibrosis 22.6%
Sinus Operation 9.7%
Treatment Noncompliance 9.7%
Malaise 6.5%
Pulmonary Function Test Decreased 6.5%
Chest Discomfort 3.2%
Liver Function Test Abnormal 3.2%
Lung Disorder 3.2%
Migraine 3.2%
Nephrolithiasis 3.2%
Non-hodgkin's Lymphoma 3.2%
Pancreatitis 3.2%
Rash 3.2%
Respiration Abnormal 3.2%
Sinusitis 3.2%
Splenomegaly 3.2%
Staphylococcal Infection 3.2%
Tonsillitis 3.2%
Weight Decreased 3.2%

Drug Data